Quantifying the Long-term Survival Benefit of Pembrolizumab for Patients With Advanced Gastric Cancer. McCaw ZR, Ludmir EB, Wei LJ. JAMA Oncol 2021;7:632-633.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

McCaw ZR, Ludmir EB, Wei LJ. Quantifying the Long-term Survival Benefit of Pembrolizumab for Patients With Advanced Gastric Cancer. JAMA Oncol 2021;7:632-633.
PMID: 33538772